BRAF Inhibition Improves Tumor Recognition by the Immune System

OncoImmunology - United States
doi 10.4161/onci.21940
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2012English

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Natural Recognition Repertoire and the Evolutionary Emergence of the Combinatorial Immune System

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2002English

Inhibition of Immune Functions by Antiviral Drugs.

Journal of Clinical Investigation
Medicine
1991English

85PMechanistic Divergence of Immune Checkpoint Inhibition by an Ex Vivo Platform Derived From Patient Tumors Where Tumor and Immune Microenvironment Is Preserved

Annals of Oncology
MedicineOncologyHematology
2017English

Modulation of Immune Responses by the Tumor Suppressor P53

BioDiscovery
2013English

A Dual-Aggressive Model of Tumor-Immune System Interactions

International journal of online and biomedical engineering
Engineering
2019English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy